Temporary ruleOregon Health Authority, Health Systems Division: Medical Assistance Programs
Oregon temporary rule amends prior authorization criteria and preferred drug list
The Oregon Health Authority has filed a temporary rule in the Oregon Bulletin that amends the prior authorization (PA) criteria and the preferred drug list (PDL) under Oregon Administrative Rules chapter 410. The change implements recommendations from a drug utilization review and pharmacy and therapeutics (DUR/P&T) action. The filing does not describe the specific changes.
- Published
- Nov 2, 2026
How to weigh in: No comment period: this is a final rule.
Administrative order DMAP 44-2026
Final ruleOregon Health Authority, Health Systems Division: Medical Assistance Programs
Oregon rule covers its move to a state-based marketplace
The Oregon Health Authority has filed a permanent rule in the Oregon Bulletin on Oregon's transition from using the Federally Facilitated Marketplace to a State-Based Marketplace, under Oregon Administrative Rules chapter 410. The filing describes only the subject and does not give a start date.
- Published
- Nov 2, 2026
How to weigh in: No comment period: this is a final rule.
Administrative order DMAP 49-2026
ProposedOregon Board of Pharmacy
Oregon Board of Pharmacy proposes rules on vaccine prescribing protocols
The Oregon Board of Pharmacy has proposed rules on prescribing pursuant to protocol, covering COVID-19, influenza and respiratory syncytial virus (RSV) vaccine protocols and standard vaccination protocols. The notice appears in the Oregon Bulletin under Oregon Administrative Rules chapter 855. If adopted, the rules would govern prescribing under these protocols.
- Published
- Nov 2, 2026
How to weigh in: No comment deadline is listed; see the document.
Oregon Bulletin notice 16382386
ProposedOregon Health Authority, Health Systems Division: Medical Assistance Programs
Oregon proposes changes to preferred drug list and prior authorization criteria
The Oregon Health Authority has proposed amendments to its preferred drug list (PDL) and prior authorization (PA) criteria, implementing recommendations from a drug utilization review and pharmacy and therapeutics (DUR/P&T) action. The notice is under Oregon Administrative Rules chapter 410 and does not describe the specific changes.
- Published
- Nov 2, 2026
How to weigh in: No comment deadline is listed; see the document.
Oregon Bulletin notice 16421482
Peer-reviewed studyCell
Industrialization reshapes gut microbes and intestinal physiology, study reports
A peer-reviewed study in the journal Cell combined microbiome and host data from populations around the world. The authors report that industrialization restructures gut microbial ecosystems, reducing microbial diversity, and alters intestinal immune and physiological responses. They also found that microbiome-based disease predictors had limited portability across populations.
- Published
- Nov 2, 2026
DOI 10.1016/j.cell.2026.10.016
Peer-reviewed studyPLOS Medicine
Antiviral stockpiles alone cannot prevent hospital overload in severe influenza pandemics
A peer-reviewed modeling study in PLOS Medicine, led by Nir Gavish, compared pandemic influenza antiviral stockpiles with hospital capacity in the United Kingdom, Japan and the United States. The authors report that stockpiles kept demand manageable in moderate scenarios, but in high-severity scenarios the daily surge of patients exceeded available hospital capacity by a factor of 5–9, even with perfect distribution of antivirals. They say their optimistic assumptions make the structural failures a lower-bound estimate, and they argue for a capacity-based approach to planning.
- Published
- Nov 3, 2026
DOI 10.1371/journal.pmed.1004992
Preprint, not peer-reviewedbioRxiv
Preprint describes human antibodies that bind a conserved influenza protein site
A preprint on bioRxiv, not yet reviewed by other scientists, led by J. Finney uses in vitro immunoassays and structural imaging to study a class of broadly protective human antibodies that binds a conserved site on influenza hemagglutinin. The authors report that recognition depends on specific germline gene variants of the antibody gene IGHV1-2, and that most people carry the necessary variants. They conclude that an immunogen displaying this site might reliably elicit broadly protective influenza antibodies in most humans.
- Published
- Nov 3, 2026
DOI 10.64898/2026.10.28.760416
Preprint, not peer-reviewedmedRxiv
Preprint says disease controls can distort estimates of transmission timing
A preprint on medRxiv, not yet reviewed by other scientists, led by K. V. Parag argues that public health interventions reshape generation times, the intervals between successive infections, for directly transmitted diseases. The authors say that ignoring this can under- or over-estimate intervention effectiveness by as much as 100% under realistic settings. They argue this bias can limit model-driven public health policy and pandemic preparedness.
- Published
- Nov 3, 2026
DOI 10.64898/2026.11.02.26367101
Preprint, not peer-reviewedbioRxiv
Preprint finds antibiotics can alter how human immune cells respond
A preprint on bioRxiv, not yet reviewed by other scientists, led by S. Hen-Avivi examined how clinically used antibiotics affect the activation of primary human immune cells. The authors report that ciprofloxacin impaired the expansion and activation of human T-cells and changed mitochondrial function, and that immune activation changed in mice after a single antibiotic dose. They conclude that antibiotics can directly affect host immunity.
- Published
- Nov 3, 2026
DOI 10.64898/2026.11.03.763842
ProposedWashington Department of Health
Washington proposes uniform hospital charity care standards
The Washington Department of Health proposes to update chapter 246-453 WAC to align hospital charity care rules with chapter 70.170 RCW, which changed after legislation in 2018 and 2022. The stated goal is to set uniform standards for charity care procedures and processes. The proposal would give more flexibility on when a responsible party can apply, raise income thresholds for eligibility, remove the sliding fee schedule of discounts, and allow assets to be considered when reducing a discount.
- Published
- Nov 4, 2026
- Comments close
- Dec 1, 2026
How to weigh in: Comment by December 1, 2026.
WSR 26-21-070
Preprint, not peer-reviewedmedRxiv
Preprint links pandemic disruption to shifts in RSV spread and evolution
A preprint on medRxiv, not yet reviewed by other scientists, led by E. Gustani-Buss analyzes genetic data on respiratory syncytial virus (RSV) before and after the COVID-19 pandemic. The authors report new RSV-A genotypes and an expanded RSV-B genotype after the pandemic, and say air-travel volume was the strongest predictor of global spread. They also report positive selection at 20 sites in key viral proteins.
- Published
- Nov 4, 2026
DOI 10.64898/2026.11.02.26367099
Preprint, not peer-reviewedmedRxiv
Preprint proposes computer tool to guide COVID-19 vaccine composition choices
A preprint on medRxiv, not yet reviewed by other scientists, led by P. Gangwar describes VaccineScout, a computational framework that recommends SARS-CoV-2 vaccine candidates by minimizing spike amino acid distances to forecast variant prevalence. The authors report that over half of spike sequences seen in the six months after vaccine selection were already circulating at the time, compared with 5–10% later. In retrospective analyses, its recommendations either matched U.S. Food and Drug Administration (FDA) recommendations or had lower spike distances to future variants.
- Published
- Nov 4, 2026
DOI 10.64898/2026.11.03.26367217